Tennessee is trying to stop Christa Pike's legal team from examining the drug used in her failed execution, creating another major battle in an already controversial case.

State officials have asked a judge to block Pike's attorneys from inspecting or testing leftover pentobarbital, the lethal injection drug used during the September execution attempt.

Their argument is that examining the drug or its packaging could expose the identity of Tennessee's confidential supplier. State officials say revealing that information could jeopardize the state's ability to obtain drugs for future executions.

But Pike's lawyers say identifying the supplier is not their goal. They want to examine how the drug was labeled, stored, transported and prepared, and whether it may have expired.
Pike, 50, survived two doses of pentobarbital during the September 30 procedure. Her attorneys say the drug may not have entered her bloodstream properly and instead pooled in her arms, leaving them burned and blistered.

She was hospitalized and placed on a ventilator for several days. After returning to prison, she reportedly said she continued to experience constant pain.
A judge had previously ordered Tennessee to preserve evidence connected to the failed execution. The state is now asking the court to restrict Pike's access to the remaining drug.
The failed procedure also led to the resignation of Tennessee's corrections commissioner and an independent review.
For now, the legal dispute continues, with Pike's attorneys seeking answers about what went wrong.